ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Clinical Research Group Of ACCC Meets

April 24, 1981

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Six Scientists Win Lasker Awards; UCLA Opens Liver Cancer Center; Foundation Honors Murphy.

September 22, 2000

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983